product image
An Ageing Population and Upcoming Therapies: What is shaping the Alzheimer’s Disease Market Scenario?

Jun 1, 2020

The ageing population is a global phenomenon. According to the UN’s “World Population Prospects 2019” by 2100, the world’s population is projected to reach approxim...

Read More
product image
R&D and Upcoming therapies Paving the Way for a Potential and Better Cure for Immune Thrombocytopenia

May 25, 2020

The Immune Thrombocytopenia market size in the 7MM was estimated to be approximately USD 2,527.72 million in 2017. The US accounts for the largest ITP Market size. A disord...

Read More
product image
Hunter Syndrome Market experiences a positive push as the pharma companies spot the untapped opportunities

May 28, 2020

The Hunter Syndrome Market is expected to grow with CAGR of 7.5% in the coming years in the 7MM. Occurring in approximately 1 in 100,000 to 1 in 170,000 male births, Hunter...

Read More
product image
Is the cure for Duchenne Muscular Dystrophy in the pipeline?

May 18, 2020

The Duchenne Muscular Dystrophy Market Size (DMD Market) in the 7MM was found to be USD 266.06 Million in 2017, during the study period (2017-2030). A rare muscle disorder,...

Read More
product image
Emerging Therapies that can significantly impact the Acute Kidney Injury Market

May 16, 2020

As per DelveInsight, Acute Kidney Injury Market Size in the 7 MM was observed to be USD 4,082.95 Million in 2017, which is expected to increase by 2030 significantly. Acute...

Read More
product image
Is the cure for Huntington’s disease on the horizon?

May 11, 2020

Several promising new developments and novel treatment approaches are fuelling Huntington’s disease Market. Progressive neurological disorders such as Parkinson disease (...

Read More
product image
Overcoming the prevailing unmet needs in Beta-Thalassemia Market

May 10, 2020

The current Beta-thalassemia market is experiencing the emergence of gene therapies as a one-time cure for the patients. Beta thalassemia is relatively a common heterogeneo...

Read More
product image
Altering the course of Ovarian cancer with emerging therapies in the horizon

Jul 14, 2020

Many players such as Immunogen, On Target Laboratories, ImmunoVaccine Technologies, OncoQuest, Precigen, and some others are involved in developing therapies to accelerate ...

Read More
product image
Novel mutation-targeting therapies in the horizon to relieve the global healthcare burden NSCLC poses

Jul 28, 2020

Non-small cell lung cancer market is anticipated to increase in the 7MM from USD 9,730 million in 2017 by 2030. Worldwide, cancer claimed the lives of approximately 9.6 mil...

Read More
product image
In the race to fight SARS-CoV-2: Merck, ISB; ViiV; Genalyte gears up

Jul 2, 2020

Merck has collaborated with the Seattle-based Institute for Systems Biology (ISB) to further study novel coronavirus SARS-CoV-2. The primary goal of the collaboration will ...

Read More
product image
Changing the Paradigm of Cancer: Neoantigen based Personalized Cancer Therapeutic Vaccines

Jul 6, 2020

Neoantigen based Personalized Cancer Therapeutic Vaccines Market is advancing owing to bioinformatics-technological advancements, improved diagnosis, and a strong pipeline....

Read More
product image
Novel coronavirus crumbles down as soon as it lands on copper

Jul 2, 2020

Research says copper disintegrates novel coronavirus – SARS-CoV-2- the moment it lands on the metal. The global coronavirus pandemic has made everyone around cautious of ...

Read More
product image
CAR-T cell therapy market for Non-Hodgkin lymphoma: Future prospects, and untapped opportunities

Jul 7, 2020

As per DelveInsight, the CAR T-Cell Therapy Market size for Non-Hodgkin lymphoma in the 6MM (the US, EU5 (the UK, Germany, France, Italy and Spain)) is expected to be USD 2...

Read More
product image
Vir’s drug shows results; Abbott launches coronavirus antibody lab test; Reprogrammed skin cells repair vision in mouse models; Moma Therapeutics focuses for molecular machines

Apr 16, 2020

Vir’s Hepatitis B drug shows positive results in phase 2 The hepatitis B drug of Vir Biotechnology has shown promising results. Its gene-silencing drug trim levels ...

Read More
product image
Supply shortage: Why ventilators are in demand amid the Coronavirus crisis

Apr 16, 2020

The Novel Coronavirus since its outbreak in Wuhan China in November-2019 has infected around 1,848,439 people with 117,217 confirmed deaths in 213 countries, till date.&nbs...

Read More